Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 359 articles:
HTML format



Single Articles


    January 2021
  1. BOUSSAC M, Arbus C, Dupouy J, Harroch E, et al
    Personality dimensions of patients can change during the course of parkinson's disease.
    PLoS One. 2021;16:e0245142.
    PubMed     Abstract available


  2. KAMIENIARZ A, Michalska J, Marszalek W, Stania M, et al
    Detection of postural control in early Parkinson's disease: Clinical testing vs. modulation of center of pressure.
    PLoS One. 2021;16:e0245353.
    PubMed     Abstract available


  3. KITANI-MORII F, Kasai T, Horiguchi G, Teramukai S, et al
    Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan.
    PLoS One. 2021;16:e0245864.
    PubMed     Abstract available


  4. SHALASH AS, Hamid E, Elrassas H, Bahbah EI, et al
    Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease.
    PLoS One. 2021;16:e0245918.
    PubMed     Abstract available


  5. FORNS J, Layton JB, Bartsch J, Turner ME, et al
    Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    PLoS One. 2021;16:e0246121.
    PubMed     Abstract available


  6. PARK KH, Sun S, Lim YH, Park HR, et al
    Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease.
    PLoS One. 2021;16:e0244133.
    PubMed     Abstract available


  7. MAHMOUDZADEH M, Wallois F, Tir M, Krystkowiak P, et al
    Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy.
    PLoS One. 2021;16:e0245188.
    PubMed     Abstract available


  8. LIN I, Edison B, Mantri S, Albert S, et al
    Triggers and alleviating factors for fatigue in Parkinson's disease.
    PLoS One. 2021;16:e0245285.
    PubMed     Abstract available


  9. SICA M, Tedesco S, Crowe C, Kenny L, et al
    Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review.
    PLoS One. 2021;16:e0246528.
    PubMed     Abstract available


  10. OVEISGHARAN S, Yu L, Bennett DA, Buchman AS, et al
    Incident mobility disability, parkinsonism, and mortality in community-dwelling older adults.
    PLoS One. 2021;16:e0246206.
    PubMed     Abstract available


  11. NAGANO T, Kakuma T, Umezu Y, Yanagawa T, et al
    Nutritional status and activities of daily living in patients with Parkinson's disease.
    PLoS One. 2021;16:e0246329.
    PubMed     Abstract available


  12. BURIL J, Burilova P, Pokorna A, Kovacova I, et al
    Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study.
    PLoS One. 2021;16:e0246342.
    PubMed     Abstract available



  13. Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
    PLoS One. 2021;16:e0247151.
    PubMed    


  14. LEE JW, Song YS, Kim H, Ku BD, et al
    Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data.
    PLoS One. 2021;16:e0246881.
    PubMed     Abstract available


  15. IIJIMA M, Okuma Y, Suzuki K, Yoshii F, et al
    Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
    PLoS One. 2021;16:e0247443.
    PubMed     Abstract available


  16. VARRECCHIA T, Castiglia SF, Ranavolo A, Conte C, et al
    An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters.
    PLoS One. 2021;16:e0244396.
    PubMed     Abstract available


  17. AGURTO C, Heisig S, Abrami A, Ho BK, et al
    Parkinson's disease medication state and severity assessment based on coordination during walking.
    PLoS One. 2021;16:e0244842.
    PubMed     Abstract available


  18. BARGIOTAS I, Kalogeratos A, Limnios M, Vidal PP, et al
    Revealing posturographic profile of patients with Parkinsonian syndromes through a novel hypothesis testing framework based on machine learning.
    PLoS One. 2021;16:e0246790.
    PubMed     Abstract available


  19. DZIECIOL K, Iordanishvili E, Abbas Z, Nahimi A, et al
    A robust method for the detection of small changes in relaxation parameters and free water content in the vicinity of the substantia nigra in Parkinson's disease patients.
    PLoS One. 2021;16:e0247552.
    PubMed     Abstract available


  20. JEONG S, Cho H, Kim YJ, Ma HI, et al
    Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
    PLoS One. 2021;16:e0247354.
    PubMed     Abstract available


  21. PHAM U, Skogseid IM, Pripp AH, Boen E, et al
    Impulsivity in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation-An exploratory study.
    PLoS One. 2021;16:e0248568.
    PubMed     Abstract available


  22. MANTRI S, Klawson E, Albert S, Rapoport R, et al
    The experience of care partners of patients with Parkinson's disease psychosis.
    PLoS One. 2021;16:e0248968.
    PubMed     Abstract available


  23. SEBATE B, Cuttler K, Cloete R, Britz M, et al
    Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
    PLoS One. 2021;16:e0249324.
    PubMed     Abstract available


  24. LOVEGROVE CJ, Bannigan K
    What is the lived experience of anxiety for people with Parkinson's? A phenomenological study.
    PLoS One. 2021;16:e0249390.
    PubMed     Abstract available


  25. SIRAGY T, Hill A, Nantel J
    Recovery of dynamic stability during slips unaffected by arm swing in people with Parkinson's Disease.
    PLoS One. 2021;16:e0249303.
    PubMed     Abstract available



  26. Correction: A genetic analysis of a Spanish population with early onset Parkinson's disease.
    PLoS One. 2021;16:e0249805.
    PubMed     Abstract available


  27. JENSEN BR, Malling ASB, Schmidt SI, Meyer M, et al
    Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease.
    PLoS One. 2021;16:e0248800.
    PubMed     Abstract available


  28. SORBERA C, Brigandi A, Cimino V, Bonanno L, et al
    The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
    PLoS One. 2021;16:e0251313.
    PubMed     Abstract available


  29. KROTINGER A, Loui P
    Rhythm and groove as cognitive mechanisms of dance intervention in Parkinson's disease.
    PLoS One. 2021;16:e0249933.
    PubMed     Abstract available


  30. LOLEKHA P, Sriphanom T, Vilaichone RK
    Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
    PLoS One. 2021;16:e0251042.
    PubMed     Abstract available


  31. FREIDLE M, Johansson H, Lebedev AV, Ekman U, et al
    Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson s disease: A feasibility study.
    PLoS One. 2021;16:e0251849.
    PubMed     Abstract available


  32. SHRESTHA S, Parks CG, Richards-Barber M, Chen H, et al
    Parkinson's disease case ascertainment in a large prospective cohort.
    PLoS One. 2021;16:e0251852.
    PubMed     Abstract available


  33. MCKAY JL, Lang KC, Bong SM, Hackney ME, et al
    Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
    PLoS One. 2021;16:e0252119.
    PubMed     Abstract available


  34. RODRIGUEZ-SABATE C, Rodriguez M, Morales I
    Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.
    PLoS One. 2021;16:e0252565.
    PubMed     Abstract available


  35. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2021;16:e0252988.
    PubMed     Abstract available


  36. SHENG MZ, Fang TC, Chen YH, Chang MH, et al
    Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
    PLoS One. 2021;16:e0252451.
    PubMed     Abstract available


  37. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available


  38. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available


  39. PEARCE P, Bulluss K, Xu SS, Kim B, et al
    How accurately are subthalamic nucleus electrodes implanted relative to the ideal stimulation location for Parkinson's disease?
    PLoS One. 2021;16:e0254504.
    PubMed     Abstract available


  40. KOYANAGI Y, Fukushi I, Nakamura M, Suzuki K, et al
    The effect of body weight-supported overground gait training for patients with Parkinson's disease: A retrospective case-control observational study.
    PLoS One. 2021;16:e0254415.
    PubMed     Abstract available


    January 2020
  41. JEON N, Bortolato M
    What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
    PLoS One. 2020;15:e0227128.
    PubMed     Abstract available


  42. YAFFE JA, Zlotnik Y, Ifergane G, Levy-Tzedek S, et al
    Implicit task switching in Parkinson's disease is preserved when on medication.
    PLoS One. 2020;15:e0227555.
    PubMed     Abstract available


  43. KAWASAKI T, Mikami K, Kamo T, Aoki R, et al
    Correction: Motor planning error in Parkinson's disease and its clinical correlates.
    PLoS One. 2020;15:e0228698.
    PubMed     Abstract available


  44. SHIIBA T, Arimura Y, Nagano M, Takahashi T, et al
    Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography.
    PLoS One. 2020;15:e0228289.
    PubMed     Abstract available


  45. GERA A, O'Keefe JA, Ouyang B, Liu Y, et al
    Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease.
    PLoS One. 2020;15:e0226494.
    PubMed     Abstract available



  46. Retraction: DJ-1 Modulates alpha-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70.
    PLoS One. 2020;15:e0219023.
    PubMed    


  47. JEONG YJ, Jeong JE, Cheon SM, Yoon BA, et al
    Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.
    PLoS One. 2020;15:e0229860.
    PubMed     Abstract available


  48. URSINO M, Magosso E, Lopane G, Calandra-Buonaura G, et al
    Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease.
    PLoS One. 2020;15:e0229729.
    PubMed     Abstract available


  49. LIMA DP, de Almeida SB, Bonfadini JC, de Luna JRG, et al
    Clinical correlates of sarcopenia and falls in Parkinson's disease.
    PLoS One. 2020;15:e0227238.
    PubMed     Abstract available


  50. LEE J, Lee AL, Park JH, Moon JE, et al
    The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    PLoS One. 2020;15:e0231010.
    PubMed     Abstract available



  51. Expression of Concern: Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1B9 Drosophila melanogaster Genetic Model of Parkinson's Disease.
    PLoS One. 2020;15:e0231371.
    PubMed    


  52. BECK EN, Wang MTY, Intzandt BN, Almeida QJ, et al
    Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2020;15:e0230803.
    PubMed     Abstract available


  53. EMELYANOV A, Shtam T, Kamyshinsky R, Garaeva L, et al
    Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid.
    PLoS One. 2020;15:e0227949.
    PubMed     Abstract available


  54. SUZUKI M, Arai M, Hayashi A, Ogino M, et al
    Adherence to treatment guideline recommendations for Parkinson's disease in Japan: A longitudinal analysis of a nationwide medical claims database between 2008 and 2016.
    PLoS One. 2020;15:e0230213.
    PubMed     Abstract available


  55. LENNAERTS-KATS H, van der Steen JT, Vijftigschild Z, Steppe M, et al
    RADPAC-PD: A tool to support healthcare professionals in timely identifying palliative care needs of people with Parkinson's disease.
    PLoS One. 2020;15:e0230611.
    PubMed     Abstract available


  56. MULCAHY G, Atwood B, Kuznetsov A
    Basal ganglia role in learning rewarded actions and executing previously learned choices: Healthy and diseased states.
    PLoS One. 2020;15:e0228081.
    PubMed     Abstract available


  57. METZGER JM, Matsoff HN, Zinnen AD, Fleddermann RA, et al
    Post mortem evaluation of inflammation, oxidative stress, and PPARgamma activation in a nonhuman primate model of cardiac sympathetic neurodegeneration.
    PLoS One. 2020;15:e0226999.
    PubMed     Abstract available


  58. OVEISGHARAN S, Dawe RJ, Leurgans SE, Yu L, et al
    Total daily physical activity, brain pathologies, and parkinsonism in older adults.
    PLoS One. 2020;15:e0232404.
    PubMed     Abstract available


  59. WU W, Sung CC, Yu P, Li J, et al
    S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    PLoS One. 2020;15:e0232019.
    PubMed     Abstract available


  60. GIANNAKAKIS E, Hutchings F, Papasavvas CA, Han CE, et al
    Computational modelling of the long-term effects of brain stimulation on the local and global structural connectivity of epileptic patients.
    PLoS One. 2020;15:e0221380.
    PubMed     Abstract available


  61. SANCHEZ-LANZAS R, Castano JG
    Correction: Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein.
    PLoS One. 2020;15:e0233091.
    PubMed     Abstract available


  62. GRUBER MT, Witte OW, Grosskreutz J, Prell T, et al
    Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study.
    PLoS One. 2020;15:e0232764.
    PubMed     Abstract available


  63. KRISHNAGOPAL S, Coelln RV, Shulman LM, Girvan M, et al
    Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks.
    PLoS One. 2020;15:e0233296.
    PubMed     Abstract available


  64. WU W, Sung CC, Yu P, Li J, et al
    Correction: S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    PLoS One. 2020;15:e0235296.
    PubMed     Abstract available


  65. KUMSA A, Agenagnew L, Alemu B, Girma S, et al
    Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    PLoS One. 2020;15:e0235365.
    PubMed     Abstract available


  66. REEDIJK M, Huss A, Verheij RA, Peeters PH, et al
    Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.
    PLoS One. 2020;15:e0234845.
    PubMed     Abstract available


  67. JUUTINEN M, Wang C, Zhu J, Haladjian J, et al
    Parkinson's disease detection from 20-step walking tests using inertial sensors of a smartphone: Machine learning approach based on an observational case-control study.
    PLoS One. 2020;15:e0236258.
    PubMed     Abstract available


  68. TERRENS AF, Soh SE, Morgan P
    The safety and feasibility of a Halliwick style of aquatic physiotherapy for falls and balance dysfunction in people with Parkinson's Disease: A single blind pilot trial.
    PLoS One. 2020;15:e0236391.
    PubMed     Abstract available


  69. CHANG YP, Lee MS, Wu DW, Tsai JH, et al
    Risk factors for depression in patients with Parkinson's disease: A nationwide nested case-control study.
    PLoS One. 2020;15:e0236443.
    PubMed     Abstract available


  70. O'DAY J, Syrkin-Nikolau J, Anidi C, Kidzinski L, et al
    The turning and barrier course reveals gait parameters for detecting freezing of gait and measuring the efficacy of deep brain stimulation.
    PLoS One. 2020;15:e0231984.
    PubMed     Abstract available


  71. CARAPELLOTTI AM, Stevenson R, Doumas M
    The efficacy of dance for improving motor impairments, non-motor symptoms, and quality of life in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0236820.
    PubMed     Abstract available


  72. SZATMARI S JR, Ajtay A, Oberfrank F, Dobi B, et al
    The prevalence of psychiatric symptoms before the diagnosis of Parkinson's disease in a nationwide cohort: A comparison to patients with cerebral infarction.
    PLoS One. 2020;15:e0236728.
    PubMed     Abstract available


  73. MICHALSKA J, Kamieniarz A, Brachman A, Marszalek W, et al
    Fall-related measures in elderly individuals and Parkinson's disease subjects.
    PLoS One. 2020;15:e0236886.
    PubMed     Abstract available


  74. HONG JY, Sunwoo MK, Yoon JH, Kang SY, et al
    Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.
    PLoS One. 2020;15:e0237472.
    PubMed     Abstract available


  75. DONG M, Li L, Chen M, Kusalik A, et al
    Predictive analysis methods for human microbiome data with application to Parkinson's disease.
    PLoS One. 2020;15:e0237779.
    PubMed     Abstract available


  76. MARTINEZ-MARTIN P, Deuschl G, Tonder L, Schnitzler A, et al
    Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.
    PLoS One. 2020;15:e0237498.
    PubMed     Abstract available


  77. LIU HC, Lin WC, Chiu MJ, Lu CH, et al
    Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology.
    PLoS One. 2020;15:e0234519.
    PubMed     Abstract available


  78. CRISTINA TP, Pablo M, Teresa PM, Lydia VD, et al
    A genetic analysis of a Spanish population with early onset Parkinson's disease.
    PLoS One. 2020;15:e0238098.
    PubMed     Abstract available


  79. FLEISHER JE, Sennott BJ, Myrick E, Niemet CJ, et al
    KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease.
    PLoS One. 2020;15:e0237777.
    PubMed     Abstract available


  80. GASPAR R, Garting T, Stradner A
    Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature alpha-synuclein fibrils.
    PLoS One. 2020;15:e0235198.
    PubMed     Abstract available


  81. NAGANUMA R, Yabe I, Takeuchi M, Morishita K, et al
    Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.
    PLoS One. 2020;15:e0232808.
    PubMed     Abstract available


  82. LI H, Liang S, Yu Y, Wang Y, et al
    Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease.
    PLoS One. 2020;15:e0238936.
    PubMed     Abstract available


  83. GAARE JJ, Nido G, Dolle C, Sztromwasser P, et al
    Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
    PLoS One. 2020;15:e0239824.
    PubMed     Abstract available


  84. SATO K, Mano T, Iwata A, Toda T, et al
    Autocorrelation-based method to identify disordered rhythm in Parkinson's disease tasks: A novel approach applicable to multimodal devices.
    PLoS One. 2020;15:e0238486.
    PubMed     Abstract available


  85. MONSELLIER E, Bendifallah M, Redeker V, Melki R, et al
    Polypeptides derived from alpha-Synuclein binding partners to prevent alpha-Synuclein fibrils interaction with and take-up by cells.
    PLoS One. 2020;15:e0237328.
    PubMed     Abstract available


  86. GLASS TJ, Kelm-Nelson CA, Szot JC, Lake JM, et al
    Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2020;15:e0240366.
    PubMed     Abstract available


  87. TANAKA R, Yamashiro K, Ogawa T, Oyama G, et al
    The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.
    PLoS One. 2020;15:e0240491.
    PubMed     Abstract available


  88. KUBOTA M, Kobayashi N, Sugizaki T, Shimoda M, et al
    Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
    PLoS One. 2020;15:e0240448.
    PubMed     Abstract available


  89. MORI Y, Yoshikawa E, Futatsubashi M, Ouchi Y, et al
    Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction.
    PLoS One. 2020;15:e0240998.
    PubMed     Abstract available



  90. Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson's disease in a rhesus monkey model.
    PLoS One. 2020;15:e0242032.
    PubMed    


  91. JENG B, Cederberg KLJ, Lai B, Sasaki JE, et al
    Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease.
    PLoS One. 2020;15:e0242136.
    PubMed     Abstract available


  92. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0240855.
    PubMed     Abstract available


  93. MALINOVA V, Pinter A, Dragaescu C, Rohde V, et al
    The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease.
    PLoS One. 2020;15:e0241752.
    PubMed     Abstract available


  94. MURUGAPPAN M, Alshuaib W, Bourisly AK, Khare SK, et al
    Tunable Q wavelet transform based emotion classification in Parkinson's disease using Electroencephalography.
    PLoS One. 2020;15:e0242014.
    PubMed     Abstract available


  95. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2020;15:e0243051.
    PubMed     Abstract available


  96. PINTO C, Salazar AP, Hennig EM, Kerr G, et al
    Dual-task walking reduces lower limb range of motion in individuals with Parkinson's disease and freezing of gait: But does it happen during what events through the gait cycle?
    PLoS One. 2020;15:e0243133.
    PubMed     Abstract available


  97. BAUMANN-VOGEL H, Hor H, Poryazova R, Valko P, et al
    REM sleep behavior in Parkinson disease: Frequent, particularly with higher age.
    PLoS One. 2020;15:e0243454.
    PubMed     Abstract available


  98. ANDERSSON N, Nilsson MH, Slaug B, Oswald F, et al
    The meaning of home questionnaire revisited: Psychometric analyses among people with Parkinson's disease reveals new dimensions.
    PLoS One. 2020;15:e0242792.
    PubMed     Abstract available


  99. TORTI M, Fossati C, Casali M, De Pandis MF, et al
    Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study.
    PLoS One. 2020;15:e0243612.
    PubMed     Abstract available


  100. PETROZZIELLO T, Dios AM, Mueller KA, Vaine CA, et al
    SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    PLoS One. 2020;15:e0243655.
    PubMed     Abstract available


  101. POLAKOVA K, Ruzicka E, Jech R, Kemlink D, et al
    3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN.
    PLoS One. 2020;15:e0244676.
    PubMed     Abstract available


  102. IBRAHIM A, Ali RAR, Manaf MRA, Ahmad N, et al
    Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.
    PLoS One. 2020;15:e0244680.
    PubMed     Abstract available


  103. SHIM M, Bang WJ, Oh CY, Lee YS, et al
    Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0244660.
    PubMed     Abstract available


  104. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0244776.
    PubMed     Abstract available


  105. EHLEN F, Al-Fatly B, Kuhn AA, Klostermann F, et al
    Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease.
    PLoS One. 2020;15:e0244148.
    PubMed     Abstract available


  106. PRAVEEN RAJNEESH C, Liou JC, Hsieh TH, Lin JH, et al
    The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.
    PLoS One. 2020;15:e0243452.
    PubMed     Abstract available


    January 2019

  107. Correction: Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    PLoS One. 2019;14:e0210931.
    PubMed     Abstract available


  108. TESSA C, Toschi N, Orsolini S, Valenza G, et al
    Central modulation of parasympathetic outflow is impaired in de novo Parkinson's disease patients.
    PLoS One. 2019;14:e0210324.
    PubMed     Abstract available


  109. HARDING Z, Wilkinson T, Stevenson A, Horrocks S, et al
    Identifying Parkinson's disease and parkinsonism cases using routinely collected healthcare data: A systematic review.
    PLoS One. 2019;14:e0198736.
    PubMed     Abstract available


  110. LANG KC, Hackney ME, Ting LH, McKay JL, et al
    Antagonist muscle activity during reactive balance responses is elevated in Parkinson's disease and in balance impairment.
    PLoS One. 2019;14:e0211137.
    PubMed     Abstract available


  111. CANARIO N, Sousa M, Moreira F, Duarte IC, et al
    Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment.
    PLoS One. 2019;14:e0210880.
    PubMed     Abstract available


  112. WON JH, Kim M, Park BY, Youn J, et al
    Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson's disease.
    PLoS One. 2019;14:e0211699.
    PubMed     Abstract available


  113. RUI Z, Qingling C, Xinyue Z, Xin Z, et al
    The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0212951.
    PubMed     Abstract available


  114. FANG YJ, Tan CH, Tu SC, Liu CY, et al
    More than an "inverted-U"? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson's disease.
    PLoS One. 2019;14:e0214146.
    PubMed     Abstract available


  115. KANG J, Derva D, Kwon DY, Wallraven C, et al
    Voluntary and spontaneous facial mimicry toward other's emotional expression in patients with Parkinson's disease.
    PLoS One. 2019;14:e0214957.
    PubMed     Abstract available


  116. ARMSTRONG MJ, Rastgardani T, Gagliardi AR, Marras C, et al
    Barriers and facilitators of communication about off periods in Parkinson's disease: Qualitative analysis of patient, carepartner, and physician Interviews.
    PLoS One. 2019;14:e0215384.
    PubMed     Abstract available


  117. NOVAK P, Pimentel Maldonado DA, Novak V
    Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study.
    PLoS One. 2019;14:e0214364.
    PubMed     Abstract available


  118. ZHONG R, Chen Q, Zhang X, Zhang X, et al
    Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0216524.
    PubMed     Abstract available


  119. CHO J, Lee YJ, Kim YH, Shin CM, et al
    Quantitative MRI evaluation of gastric motility in patients with Parkinson's disease: Correlation of dyspeptic symptoms with volumetry and motility indices.
    PLoS One. 2019;14:e0216396.
    PubMed     Abstract available


  120. FLORENCIO RB, da Nobrega AJS, Lima INDF, Gualdi LP, et al
    Chest wall volume and asynchrony in stroke and Parkinson's disease subjects: A case-control study.
    PLoS One. 2019;14:e0216641.
    PubMed     Abstract available


  121. KANG J, Derva D, Kwon DY, Wallraven C, et al
    Correction: Voluntary and spontaneous facial mimicry toward other's emotional expression in patients with Parkinson's disease.
    PLoS One. 2019;14:e0217715.
    PubMed     Abstract available


  122. IZZO VA, Donati MA, Ramat S, Primi C, et al
    Impulse control disorders in Parkinson's disease: A systematic review on the psychometric properties of the existing measures.
    PLoS One. 2019;14:e0217700.
    PubMed     Abstract available


  123. HOPE TR, Selnes P, Rektorova I, Anderkova L, et al
    Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    PLoS One. 2019;14:e0217922.
    PubMed     Abstract available


  124. LEE GB, Woo H, Lee SY, Cheon SM, et al
    The burden of care and the understanding of disease in Parkinson's disease.
    PLoS One. 2019;14:e0217581.
    PubMed     Abstract available


  125. CHEN YY, Fan HC, Tung MC, Chang YK, et al
    The association between Parkinson's disease and temporomandibular disorder.
    PLoS One. 2019;14:e0217763.
    PubMed     Abstract available


  126. NUNES A, Silva G, Duque C, Januario C, et al
    Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls.
    PLoS One. 2019;14:e0218826.
    PubMed     Abstract available


  127. YANG YR, Cheng SJ, Lee YJ, Liu YC, et al
    Cognitive and motor dual task gait training exerted specific training effects on dual task gait performance in individuals with Parkinson's disease: A randomized controlled pilot study.
    PLoS One. 2019;14:e0218180.
    PubMed     Abstract available


  128. LAN BL, Yeo JHW
    Comparison of computer-key-hold-time and alternating-finger-tapping tests for early-stage Parkinson's disease.
    PLoS One. 2019;14:e0219114.
    PubMed     Abstract available


  129. MIHAILA D, Donegan J, Barns S, LaRocca D, et al
    The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.
    PLoS One. 2019;14:e0218252.
    PubMed     Abstract available


  130. CERESNAK SR, Pass RH, Dubin AM, Yang L, et al
    Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome.
    PLoS One. 2019;14:e0217282.
    PubMed     Abstract available


  131. SAKAI R, Suzuki M, Ueyama M, Takeuchi T, et al
    E46K mutant alpha-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type alpha-synuclein in Drosophila models of Parkinson's disease.
    PLoS One. 2019;14:e0218261.
    PubMed     Abstract available


  132. POLYCHRONIS S, Dervenoulas G, Yousaf T, Niccolini F, et al
    Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naive Parkinson's patients.
    PLoS One. 2019;14:e0214352.
    PubMed     Abstract available


  133. STEVENSON SA, Ciucci MR, Kelm-Nelson CA
    Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2019;14:e0220734.
    PubMed     Abstract available


  134. JANSSEN S, Heijs JJA, van der Meijs W, Nonnekes J, et al
    Validation of the Auditory Stroop Task to increase cognitive load in walking tasks in healthy elderly and persons with Parkinson's disease.
    PLoS One. 2019;14:e0220735.
    PubMed     Abstract available


  135. ISAACS BR, Trutti AC, Pelzer E, Tittgemeyer M, et al
    Cortico-basal white matter alterations occurring in Parkinson's disease.
    PLoS One. 2019;14:e0214343.
    PubMed     Abstract available


  136. CHOI JH, Kim HJ, Lee JY, Yoo D, et al
    Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    PLoS One. 2019;14:e0221219.
    PubMed     Abstract available


  137. SAKHARKAR MK, Kashmir Singh SK, Rajamanickam K, Mohamed Essa M, et al
    A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson's disease.
    PLoS One. 2019;14:e0220995.
    PubMed     Abstract available


  138. OWENS-WALTON C, Jakabek D, Power BD, Walterfang M, et al
    Increased functional connectivity of thalamic subdivisions in patients with Parkinson's disease.
    PLoS One. 2019;14:e0222002.
    PubMed     Abstract available


  139. VIKENE K, Skeie GO, Specht K
    Subjective judgments of rhythmic complexity in Parkinson's disease: Higher baseline, preserved relative ability, and modulated by tempo.
    PLoS One. 2019;14:e0221752.
    PubMed     Abstract available


  140. STEGEMOLLER EL, Zaman A, Uzochukwu J
    Repetitive finger movement and circle drawing in persons with Parkinson's disease.
    PLoS One. 2019;14:e0222862.
    PubMed     Abstract available


  141. BORDONI L, Gabbianelli R, Fedeli D, Fiorini D, et al
    Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease.
    PLoS One. 2019;14:e0223238.
    PubMed     Abstract available


  142. TSATALI M, Overton PG, Vivas AB
    Self-reported and experimentally induced self-disgust is heightened in Parkinson's disease: Contribution of behavioural symptoms.
    PLoS One. 2019;14:e0223663.
    PubMed     Abstract available


  143. ZHU Y, Pu J, Chen Y, Zhang B, et al
    Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.
    PLoS One. 2019;14:e0224236.
    PubMed     Abstract available


  144. LEI C, Sunzi K, Dai F, Liu X, et al
    Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson's disease: A systematic review.
    PLoS One. 2019;14:e0224819.
    PubMed     Abstract available


  145. SATO K, Nagashima Y, Mano T, Iwata A, et al
    Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning-based 2D pose estimator.
    PLoS One. 2019;14:e0223549.
    PubMed     Abstract available


  146. PINKHARDT EH, Liu H, Ma D, Chen J, et al
    Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test.
    PLoS One. 2019;14:e0224331.
    PubMed     Abstract available


  147. KALILANI L, Friesen D, Boudiaf N, Asgharnejad M, et al
    The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study.
    PLoS One. 2019;14:e0225723.
    PubMed     Abstract available


  148. MAEGAWA H, Adachi N, Hanamoto H, Kudo C, et al
    Bilateral Parkinson's disease model rats exhibit hyperalgesia to subcutaneous formalin administration into the vibrissa pad.
    PLoS One. 2019;14:e0225928.
    PubMed     Abstract available


  149. CHEN F, Wu T, Luo Y, Li Z, et al
    Amnestic mild cognitive impairment in Parkinson's disease: White matter structural changes and mechanisms.
    PLoS One. 2019;14:e0226175.
    PubMed     Abstract available


  150. MARTINEZ A, Ibarra IA, Vargas R
    A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.
    PLoS One. 2019;14:e0224691.
    PubMed     Abstract available


  151. READ J, Cable S, Lofqvist C, Iwarsson S, et al
    Experiences of health services and unmet care needs of people with late-stage Parkinson's in England: A qualitative study.
    PLoS One. 2019;14:e0226916.
    PubMed     Abstract available


  152. VAN DIGGELEN F, Hrle D, Apetri M, Christiansen G, et al
    Two conformationally distinct alpha-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
    PLoS One. 2019;14:e0213663.
    PubMed     Abstract available


  153. NGUYEN TAK, Djilas M, Nowacki A, Mercanzini A, et al
    Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus.
    PLoS One. 2019;14:e0217985.
    PubMed     Abstract available


  154. CALLIZOT N, Combes M, Henriques A, Poindron P, et al
    Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
    PLoS One. 2019;14:e0215277.
    PubMed     Abstract available


  155. OSUAGWU N, Dolle C, Tzoulis C
    Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or alpha-synuclein, is localized to the mitochondrial matrix.
    PLoS One. 2019;14:e0219909.
    PubMed     Abstract available


  156. RUESINK H, Reimer L, Gregersen E, Moeller A, et al
    Stabilization of alpha-synuclein oligomers using formaldehyde.
    PLoS One. 2019;14:e0216764.
    PubMed     Abstract available


  157. TSANG AR, Rajakumar N, Jog MS
    Botulinum toxin A injection into the entopeduncular nucleus improves dynamic locomotory parameters in hemiparkinsonian rats.
    PLoS One. 2019;14:e0223450.
    PubMed     Abstract available


  158. UGOLINO J, Dziki KM, Kim A, Wu JJ, et al
    Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity.
    PLoS One. 2019;14:e0220849.
    PubMed     Abstract available


    January 2018
  159. REKTOR I, Svatkova A, Vojtisek L, Zikmundova I, et al
    White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.
    PLoS One. 2018;13:e0187939.
    PubMed     Abstract available


  160. SHAO YM, Ma X, Paira P, Tan A, et al
    Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment.
    PLoS One. 2018;13:e0188212.
    PubMed     Abstract available


  161. YONEYAMA N, Watanabe H, Kawabata K, Bagarinao E, et al
    Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson's disease.
    PLoS One. 2018;13:e0190072.
    PubMed     Abstract available


  162. BAILLE G, Perez T, Devos D, Deken V, et al
    Early occurrence of inspiratory muscle weakness in Parkinson's disease.
    PLoS One. 2018;13:e0190400.
    PubMed     Abstract available


  163. ABUR D, Lester-Smith RA, Daliri A, Lupiani AA, et al
    Sensorimotor adaptation of voice fundamental frequency in Parkinson's disease.
    PLoS One. 2018;13:e0191839.
    PubMed     Abstract available


  164. JEHANGIR N, Yu CY, Song J, Shariati MA, et al
    Slower saccadic reading in Parkinson's disease.
    PLoS One. 2018;13:e0191005.
    PubMed     Abstract available


  165. WU YH, Chen YH, Chang MH, Lin CH, et al
    Depression in Parkinson's disease: A case-control study.
    PLoS One. 2018;13:e0192050.
    PubMed     Abstract available


  166. JAZAERI SZ, Azad A, Mehdizadeh H, Habibi SA, et al
    The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease.
    PLoS One. 2018;13:e0192168.
    PubMed     Abstract available


  167. FIGURA M, Kusmierska K, Bucior E, Szlufik S, et al
    Serum amino acid profile in patients with Parkinson's disease.
    PLoS One. 2018;13:e0191670.
    PubMed     Abstract available


  168. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Abstract available


  169. PUSHPANATHAN ME, Loftus AM, Gasson N, Thomas MG, et al
    Beyond factor analysis: Multidimensionality and the Parkinson's Disease Sleep Scale-Revised.
    PLoS One. 2018;13:e0192394.
    PubMed     Abstract available


  170. DA SILVA FC, Iop RDR, de Oliveira LC, Boll AM, et al
    Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years.
    PLoS One. 2018;13:e0193113.
    PubMed     Abstract available


  171. WOOD PL, Tippireddy S, Feriante J, Woltjer RL, et al
    Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease.
    PLoS One. 2018;13:e0191815.
    PubMed     Abstract available


  172. MARRONE L, Bus C, Schondorf D, Fitzgerald JC, et al
    Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease.
    PLoS One. 2018;13:e0192497.
    PubMed     Abstract available


  173. SORENSEN DM, Holemans T, van Veen S, Martin S, et al
    Parkinson disease related ATP13A2 evolved early in animal evolution.
    PLoS One. 2018;13:e0193228.
    PubMed     Abstract available


  174. LIN FY, Yang YC, Lin CL, Lee LJ, et al
    Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study.
    PLoS One. 2018;13:e0193783.
    PubMed     Abstract available


  175. PRETORIUS E, Page MJ, Mbotwe S, Kell DB, et al
    Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
    PLoS One. 2018;13:e0192121.
    PubMed     Abstract available


  176. STAHL K, Rahmani S, Prydz A, Skauli N, et al
    Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.
    PLoS One. 2018;13:e0194896.
    PubMed     Abstract available


  177. KRIBUS-SHMIEL L, Zeilig G, Sokolovski B, Plotnik M, et al
    How many strides are required for a reliable estimation of temporal gait parameters? Implementation of a new algorithm on the phase coordination index.
    PLoS One. 2018;13:e0192049.
    PubMed     Abstract available


  178. JEHU DA, Cantu H, Hill A, Paquette C, et al
    Medication and trial duration influence postural and pointing parameters during a standing repetitive pointing task in individuals with Parkinson's disease.
    PLoS One. 2018;13:e0195322.
    PubMed     Abstract available


  179. KIM KH, Kang SY, Shin DA, Yi S, et al
    Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery.
    PLoS One. 2018;13:e0195749.
    PubMed     Abstract available


  180. YOSHIDA T, Masani K, Zabjek K, Popovic MR, et al
    Dynamic cortical participation during bilateral, cyclical ankle movements: Effects of Parkinson's disease.
    PLoS One. 2018;13:e0196177.
    PubMed     Abstract available


  181. BADEA L, Onu M, Wu T, Roceanu A, et al
    Correction: Exploring the reproducibility of functional connectivity alterations in Parkinson's disease.
    PLoS One. 2018;13:e0197121.
    PubMed     Abstract available


  182. TURCATO AM, Godi M, Giardini M, Arcolin I, et al
    Abnormal gait pattern emerges during curved trajectories in high-functioning Parkinsonian patients walking in line at normal speed.
    PLoS One. 2018;13:e0197264.
    PubMed     Abstract available


  183. SALAMA M, Shalash A, Magdy A, Makar M, et al
    Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases.
    PLoS One. 2018;13:e0196436.
    PubMed     Abstract available


  184. TEJERA-PARRADO C, Jesus S, Lopez-Ruiz A, Buiza-Rueda D, et al
    TMEM230 in Parkinson's disease in a southern Spanish population.
    PLoS One. 2018;13:e0197271.
    PubMed     Abstract available


  185. MA J, Ma S, Zou H, Zhang Y, et al
    Impaired serial ordering in nondemented patients with mild Parkinson's disease.
    PLoS One. 2018;13:e0197489.
    PubMed     Abstract available


  186. LEE HJ, Uhm JS, Hong YJ, Hur J, et al
    Altered myocardial characteristics of the preexcited segment in Wolff-Parkinson-White syndrome: A pilot study with cardiac magnetic resonance imaging.
    PLoS One. 2018;13:e0198218.
    PubMed     Abstract available


  187. KAWASHIMA S, Ueki Y, Kato T, Ito K, et al
    Reduced striatal dopamine release during motor skill acquisition in Parkinson's disease.
    PLoS One. 2018;13:e0196661.
    PubMed     Abstract available


  188. MARSHALL MS, Jakubauskas B, Bogue W, Stoskute M, et al
    Analysis of age-related changes in psychosine metabolism in the human brain.
    PLoS One. 2018;13:e0193438.
    PubMed     Abstract available


  189. TOMITA S, Oeda T, Umemura A, Kohsaka M, et al
    Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease.
    PLoS One. 2018;13:e0197608.
    PubMed     Abstract available


  190. SCHNEIDER JS
    Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
    PLoS One. 2018;13:e0199189.
    PubMed     Abstract available


  191. JUSTE FS, Sassi FC, Costa JB, de Andrade CRF, et al
    Frequency of speech disruptions in Parkinson's Disease and developmental stuttering: A comparison among speech tasks.
    PLoS One. 2018;13:e0199054.
    PubMed     Abstract available


  192. WANG SM, Tickle-Degnen L
    Emotional cues from expressive behavior of women and men with Parkinson's disease.
    PLoS One. 2018;13:e0199886.
    PubMed     Abstract available


  193. WEI L, Zhang J, Long Z, Wu GR, et al
    Correction: Reduced Topological Efficiency in Cortical-Basal Ganglia Motor Network of Parkinson's Disease: A Resting State fMRI Study.
    PLoS One. 2018;13:e0200623.
    PubMed     Abstract available


  194. WU CH, Yang BH, Chou YH, Wang SJ, et al
    Effects of 99mTc-TRODAT-1 drug template on image quantitative analysis.
    PLoS One. 2018;13:e0194503.
    PubMed     Abstract available


  195. CHEN NK, Chang HC, Bilgin A, Bernstein A, et al
    A diffusion-matched principal component analysis (DM-PCA) based two-channel denoising procedure for high-resolution diffusion-weighted MRI.
    PLoS One. 2018;13:e0195952.
    PubMed     Abstract available


  196. SANCHEZ-LANZAS R, Castano JG
    Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein.
    PLoS One. 2018;13:e0201152.
    PubMed     Abstract available


  197. OHMICHI T, Kasai T, Kosaka T, Shikata K, et al
    Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.
    PLoS One. 2018;13:e0201260.
    PubMed     Abstract available


  198. LASSEN LB, Gregersen E, Isager AK, Betzer C, et al
    ELISA method to detect alpha-synuclein oligomers in cell and animal models.
    PLoS One. 2018;13:e0196056.
    PubMed     Abstract available


  199. BEYLE A, Glonnegger H, Cerff B, Graber S, et al
    The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson's disease.
    PLoS One. 2018;13:e0200990.
    PubMed     Abstract available


  200. CHOI MG, Kim MJ, Kim DG, Yu R, et al
    Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
    PLoS One. 2018;13:e0195339.
    PubMed     Abstract available


  201. LARSSON V, Torisson G, Londos E
    Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia.
    PLoS One. 2018;13:e0202044.
    PubMed     Abstract available


  202. CHAHINE LM, Urbe L, Caspell-Garcia C, Aarsland D, et al
    Cognition among individuals along a spectrum of increased risk for Parkinson's disease.
    PLoS One. 2018;13:e0201964.
    PubMed     Abstract available


  203. KAWASAKI T, Mikami K, Kamo T, Aoki R, et al
    Motor planning error in Parkinson's disease and its clinical correlates.
    PLoS One. 2018;13:e0202228.
    PubMed     Abstract available


  204. CHOUDHURY GR, Daadi MM
    Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.
    PLoS One. 2018;13:e0202770.
    PubMed     Abstract available


  205. LAI CY, Chiang JH, Lin JG, Yen HR, et al
    Chinese herbal medicine reduced the risk of stroke in patients with Parkinson's disease: A population-based retrospective cohort study from Taiwan.
    PLoS One. 2018;13:e0203473.
    PubMed     Abstract available


  206. PERLBARG V, Lambert J, Butler B, Felfli M, et al
    Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    PLoS One. 2018;13:e0202597.
    PubMed     Abstract available


  207. SUPANDI F, van Beek JHGM
    Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.
    PLoS One. 2018;13:e0203687.
    PubMed     Abstract available


  208. LEE Y, Oh JS, Chung SJ, Lee JJ, et al
    The presence of depression in de novo Parkinson's disease reflects poor motor compensation.
    PLoS One. 2018;13:e0203303.
    PubMed     Abstract available


  209. HILLER AL, Murchison CF, Lobb BM, O'Connor S, et al
    A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
    PLoS One. 2018;13:e0203637.
    PubMed     Abstract available


  210. MALLING ASB, Morberg BM, Wermuth L, Gredal O, et al
    Effect of transcranial pulsed electromagnetic fields (T-PEMF) on functional rate of force development and movement speed in persons with Parkinson's disease: A randomized clinical trial.
    PLoS One. 2018;13:e0204478.
    PubMed     Abstract available


  211. ONGUN N
    Does nutritional status affect Parkinson's Disease features and quality of life?
    PLoS One. 2018;13:e0205100.
    PubMed     Abstract available


  212. T DOS SANTOS MC, Scheller D, Schulte C, Mesa IR, et al
    Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis.
    PLoS One. 2018;13:e0206536.
    PubMed     Abstract available


  213. GARZO A, Silva PA, Garay-Vitoria N, Hernandez E, et al
    Design and development of a gait training system for Parkinson's disease.
    PLoS One. 2018;13:e0207136.
    PubMed     Abstract available


  214. DANESHZAND M, Faezipour M, Barkana BD
    Robust desynchronization of Parkinson's disease pathological oscillations by frequency modulation of delayed feedback deep brain stimulation.
    PLoS One. 2018;13:e0207761.
    PubMed     Abstract available


  215. HURTADO-POMARES M, Terol-Cantero MC, Sanchez-Perez A, Leiva-Santana C, et al
    Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    PLoS One. 2018;13:e0207698.
    PubMed     Abstract available


  216. OUERFELLI-ETHIER J, Elsaeid B, Desgroseilliers J, Munoz DP, et al
    Anti-saccades predict cognitive functions in older adults and patients with Parkinson's disease.
    PLoS One. 2018;13:e0207589.
    PubMed     Abstract available


  217. CANTU H, Cote JN, Nantel J
    A new method based on quiet stance baseline is more effective in identifying freezing in Parkinson's disease.
    PLoS One. 2018;13:e0207945.
    PubMed     Abstract available


  218. OKUBADEJO NU, Rizig M, Ojo OO, Jonvik H, et al
    Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.
    PLoS One. 2018;13:e0207984.
    PubMed     Abstract available


  219. HONMA M, Masaoka Y, Koyama S, Kuroda T, et al
    Impaired cognitive modification for estimating time duration in Parkinson's disease.
    PLoS One. 2018;13:e0208956.
    PubMed     Abstract available


  220. WILLKOMMEN D, Lucio M, Moritz F, Forcisi S, et al
    Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.
    PLoS One. 2018;13:e0208752.
    PubMed     Abstract available


  221. SUZUKI A, Ito M, Hamaguchi T, Mori H, et al
    Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.
    PLoS One. 2018;13:e0208313.
    PubMed     Abstract available


  222. HAEGELEN C, Baumgarten C, Houvenaghel JF, Zhao Y, et al
    Functional atlases for analysis of motor and neuropsychological outcomes after medial globus pallidus and subthalamic stimulation.
    PLoS One. 2018;13:e0200262.
    PubMed     Abstract available


  223. ARNULFO G, Pozzi NG, Palmisano C, Leporini A, et al
    Phase matters: A role for the subthalamic network during gait.
    PLoS One. 2018;13:e0198691.
    PubMed     Abstract available


  224. DUCHIN Y, Shamir RR, Patriat R, Kim J, et al
    Patient-specific anatomical model for deep brain stimulation based on 7 Tesla MRI.
    PLoS One. 2018;13:e0201469.
    PubMed     Abstract available


  225. TYULMANKOV D, Tass PA, Bokil H
    Periodic flashing coordinated reset stimulation paradigm reduces sensitivity to ON and OFF period durations.
    PLoS One. 2018;13:e0203782.
    PubMed     Abstract available


  226. SHIMONY JS, Rutlin J, Karimi M, Tian L, et al
    Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques.
    PLoS One. 2018;13:e0202201.
    PubMed     Abstract available


  227. STILES L, Zheng Y, Smith PF
    The effects of electrical stimulation of the peripheral vestibular system on neurochemical release in the rat striatum.
    PLoS One. 2018;13:e0205869.
    PubMed     Abstract available


  228. LIN W, Xie YC, Cheng PY, Dong LY, et al
    Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies.
    PLoS One. 2018;13:e0205909.
    PubMed     Abstract available


  229. KLYUZHIN IS, Fu JF, Hong A, Sacheli M, et al
    Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration.
    PLoS One. 2018;13:e0206607.
    PubMed     Abstract available


    January 2017
  230. TRENADO C, Elben S, Friggemann L, Gruhn S, et al
    Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    PLoS One. 2017;12:e0168151.
    PubMed     Abstract available


  231. RICCIARDI L, Visco-Comandini F, Erro R, Morgante F, et al
    Facial Emotion Recognition and Expression in Parkinson's Disease: An Emotional Mirror Mechanism?
    PLoS One. 2017;12:e0169110.
    PubMed     Abstract available


  232. JING H, Wang S, Wang M, Fu W, et al
    Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-kappaB Pathway.
    PLoS One. 2017;12:e0169560.
    PubMed     Abstract available


  233. YAMAMOTO T, Asahina M, Yamanaka Y, Uchiyama T, et al
    The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson's Disease.
    PLoS One. 2017;12:e0169405.
    PubMed     Abstract available


  234. STOTT SR, Hayat S, Carnwath T, Garas S, et al
    CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0171748.
    PubMed     Abstract available


  235. ZEISS CJ, Allore HG, Beck AP
    Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease.
    PLoS One. 2017;12:e0171790.
    PubMed     Abstract available


  236. PAUL R, Choudhury A, Kumar S, Giri A, et al
    Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    PLoS One. 2017;12:e0171285.
    PubMed     Abstract available


  237. CIESIELSKA A, Samaranch L, San Sebastian W, Dickson DW, et al
    Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    PLoS One. 2017;12:e0169965.
    PubMed     Abstract available



  238. Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity.
    PLoS One. 2017;12:e0172775.
    PubMed     Abstract available


  239. VASTA R, Nicoletti A, Mostile G, Dibilio V, et al
    Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
    PLoS One. 2017;12:e0172145.
    PubMed     Abstract available


  240. CHAN RB, Perotte AJ, Zhou B, Liong C, et al
    Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.
    PLoS One. 2017;12:e0172348.
    PubMed     Abstract available


  241. NACKAERTS E, Heremans E, Smits-Engelsman BC, Broeder S, et al
    Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease.
    PLoS One. 2017;12:e0173157.
    PubMed     Abstract available


  242. LU J, Li X, Wang Q, Pei G, et al
    Dopamine D2 receptor and beta-arrestin 2 mediate Amyloid-beta elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cells.
    PLoS One. 2017;12:e0173240.
    PubMed     Abstract available


  243. WESTPHAL R, Simmons C, Mesquita MB, Wood TC, et al
    Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson's disease.
    PLoS One. 2017;12:e0172394.
    PubMed     Abstract available


  244. WENG CC, Chen ZA, Chao KT, Ee TW, et al
    Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    PLoS One. 2017;12:e0173503.
    PubMed     Abstract available


  245. FUJIWARA M, Ding C, Kaunitz L, Stout JC, et al
    Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease.
    PLoS One. 2017;12:e0173707.
    PubMed     Abstract available


  246. WEN M, Zhou B, Chen YH, Ma ZL, et al
    Serum uric acid levels in patients with Parkinson's disease: A meta-analysis.
    PLoS One. 2017;12:e0173731.
    PubMed     Abstract available


  247. HUERTAS I, Jesus S, Lojo JA, Garcia-Gomez FJ, et al
    Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0174644.
    PubMed     Abstract available


  248. YAN H, Wang J
    Quantification of motor network dynamics in Parkinson's disease by means of landscape and flux theory.
    PLoS One. 2017;12:e0174364.
    PubMed     Abstract available


  249. ROZANI V, Giladi N, El-Ad B, Gurevich T, et al
    Statin adherence and the risk of Parkinson's disease: A population-based cohort study.
    PLoS One. 2017;12:e0175054.
    PubMed     Abstract available


  250. TRENADO C, Elben S, Friggemann L, Gruhn S, et al
    Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease.
    PLoS One. 2017;12:e0175602.
    PubMed     Abstract available


  251. PATERNITI I, Campolo M, Siracusa R, Cordaro M, et al
    Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease.
    PLoS One. 2017;12:e0174470.
    PubMed     Abstract available


  252. PIERCE S, Coetzee GA
    Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
    PLoS One. 2017;12:e0175882.
    PubMed     Abstract available


  253. HUERTAS I, Jesus S, Garcia-Gomez FJ, Lojo JA, et al
    Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.
    PLoS One. 2017;12:e0175560.
    PubMed     Abstract available


  254. FLORES ALVES DOS SANTOS J, Tezenas du Montcel S, Gargiulo M, Behar C, et al
    Tackling psychosocial maladjustment in Parkinson's disease patients following subthalamic deep-brain stimulation: A randomised clinical trial.
    PLoS One. 2017;12:e0174512.
    PubMed     Abstract available


  255. BUTCHER NJ, Merico D, Zarrei M, Ogura L, et al
    Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease.
    PLoS One. 2017;12:e0173944.
    PubMed     Abstract available


  256. ALKEMADE A, de Hollander G, Keuken MC, Schafer A, et al
    Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI.
    PLoS One. 2017;12:e0176130.
    PubMed     Abstract available



  257. Correction: Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
    PLoS One. 2017;12:e0176628.
    PubMed     Abstract available


  258. ARTZI M, Even-Sapir E, Lerman Shacham H, Thaler A, et al
    DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.
    PLoS One. 2017;12:e0175424.
    PubMed     Abstract available


  259. ALAM MN, Garg A, Munia TTK, Fazel-Rezai R, et al
    Vertical ground reaction force marker for Parkinson's disease.
    PLoS One. 2017;12:e0175951.
    PubMed     Abstract available


  260. MOONEN AJH, Weiss PH, Wiesing M, Weidner R, et al
    An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?
    PLoS One. 2017;12:e0177085.
    PubMed     Abstract available


  261. ANGWIN AJ, Dissanayaka NNW, McMahon KL, Silburn PA, et al
    Lexical ambiguity resolution during sentence processing in Parkinson's disease: An event-related potential study.
    PLoS One. 2017;12:e0176281.
    PubMed     Abstract available


  262. CASPELL-GARCIA C, Simuni T, Tosun-Turgut D, Wu IW, et al
    Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
    PLoS One. 2017;12:e0175674.
    PubMed     Abstract available


  263. BHATNAGAR M, Goel I, Roy T, Shukla SD, et al
    Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice.
    PLoS One. 2017;12:e0177254.
    PubMed     Abstract available


  264. GARCIA-MARTIN E, Pablo LE, Bambo MP, Alarcia R, et al
    Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease.
    PLoS One. 2017;12:e0177163.
    PubMed     Abstract available


  265. AKHTAR RS, Xie SX, Chen YJ, Rick J, et al
    Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia.
    PLoS One. 2017;12:e0177924.
    PubMed     Abstract available


  266. BETTECKEN K, Bernhard F, Sartor J, Hobert MA, et al
    No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson's disease.
    PLoS One. 2017;12:e0176816.
    PubMed     Abstract available


  267. SAMOTUS O, Lee J, Jog M
    Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
    PLoS One. 2017;12:e0178670.
    PubMed     Abstract available


  268. HAYETE B, Wuest D, Laramie J, McDonagh P, et al
    A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease.
    PLoS One. 2017;12:e0178982.
    PubMed     Abstract available


  269. WANG L, Wang Z, Zhu R, Bi J, et al
    Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
    PLoS One. 2017;12:e0179476.
    PubMed     Abstract available


  270. TU XJ, Hwang WJ, Ma HI, Chang LH, et al
    Determinants of generic and specific health-related quality of life in patients with Parkinson's disease.
    PLoS One. 2017;12:e0178896.
    PubMed     Abstract available


  271. SHAHGHOLI L, De Jesus S, Wu SS, Pei Q, et al
    Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.
    PLoS One. 2017;12:e0180425.
    PubMed     Abstract available


  272. KIM Y, Seok JM, Park J, Kim KH, et al
    The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism.
    PLoS One. 2017;12:e0180744.
    PubMed     Abstract available


  273. WU MC, Xu X, Chen SM, Tyan YS, et al
    Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    PLoS One. 2017;12:e0175836.
    PubMed     Abstract available


  274. MIKAMI K, Shiraishi M, Kawasaki T, Kamo T, et al
    Forward flexion of trunk in Parkinson's disease patients is affected by subjective vertical position.
    PLoS One. 2017;12:e0181210.
    PubMed     Abstract available


  275. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Abstract available


  276. SCHWENKGRUB J, Zaremba M, Joniec-Maciejak I, Cudna A, et al
    The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease.
    PLoS One. 2017;12:e0182019.
    PubMed     Abstract available


  277. WU PL, Lee M, Huang TT
    Effectiveness of physical activity on patients with depression and Parkinson's disease: A systematic review.
    PLoS One. 2017;12:e0181515.
    PubMed     Abstract available


  278. NAPOLITANO F, Booth Warren E, Migliarini S, Punzo D, et al
    Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
    PLoS One. 2017;12:e0181677.
    PubMed     Abstract available


  279. MODO M, Crum WR, Gerwig M, Vernon AC, et al
    Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.
    PLoS One. 2017;12:e0180733.
    PubMed     Abstract available


  280. LOPEZ A, Ortiz F, Doerrier C, Venegas C, et al
    Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
    PLoS One. 2017;12:e0183090.
    PubMed     Abstract available


  281. ERDOGDU SAKAR B, Serbes G, Sakar CO
    Analyzing the effectiveness of vocal features in early telediagnosis of Parkinson's disease.
    PLoS One. 2017;12:e0182428.
    PubMed     Abstract available


  282. KIM HW, Oh M, Oh JS, Oh SJ, et al
    Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    PLoS One. 2017;12:e0169928.
    PubMed     Abstract available


  283. VELARDE OM, Mato G, Dellavale D
    Mechanisms for pattern specificity of deep-brain stimulation in Parkinson's disease.
    PLoS One. 2017;12:e0182884.
    PubMed     Abstract available


  284. CHEN CY, Hung HJ, Chang KH, Hsu CY, et al
    Long-term exposure to air pollution and the incidence of Parkinson's disease: A nested case-control study.
    PLoS One. 2017;12:e0182834.
    PubMed     Abstract available


  285. BARRANTES S, Sanchez Egea AJ, Gonzalez Rojas HA, Marti MJ, et al
    Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer.
    PLoS One. 2017;12:e0183843.
    PubMed     Abstract available


  286. GAUVIN HS, Mertens J, Marien P, Santens P, et al
    Verbal monitoring in Parkinson's disease: A comparison between internal and external monitoring.
    PLoS One. 2017;12:e0182159.
    PubMed     Abstract available


  287. DALE ML, Horak FB, Wright WG, Schoneburg BM, et al
    Impaired perception of surface tilt in progressive supranuclear palsy.
    PLoS One. 2017;12:e0173351.
    PubMed     Abstract available


  288. KARAMINTZIOU SD, Custodio AL, Piallat B, Polosan M, et al
    Algorithmic design of a noise-resistant and efficient closed-loop deep brain stimulation system: A computational approach.
    PLoS One. 2017;12:e0171458.
    PubMed     Abstract available


  289. POKRZYWA M, Pawelek K, Kucia WE, Sarbak S, et al
    Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease.
    PLoS One. 2017;12:e0184117.
    PubMed     Abstract available


  290. LI T, Li W, Yang Y, Zhang W, et al
    Classification of brain disease in magnetic resonance images using two-stage local feature fusion.
    PLoS One. 2017;12:e0171749.
    PubMed     Abstract available


  291. RODRIGUEZ-MARTIN D, Sama A, Perez-Lopez C, Catala A, et al
    Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer.
    PLoS One. 2017;12:e0171764.
    PubMed     Abstract available


  292. PEPPOLONI L, Lawrence EL, Ruffaldi E, Valero-Cuevas FJ, et al
    Characterization of the disruption of neural control strategies for dynamic fingertip forces from attractor reconstruction.
    PLoS One. 2017;12:e0172025.
    PubMed     Abstract available


  293. DELVAL A, Defebvre L, Tard C
    Freezing during tapping tasks in patients with advanced Parkinson's disease and freezing of gait.
    PLoS One. 2017;12:e0181973.
    PubMed     Abstract available


  294. GEORGIOU A, Demetriou CA, Heraclides A, Christou YP, et al
    Mitochondrial superclusters influence age of onset of Parkinson's disease in a gender specific manner in the Cypriot population: A case-control study.
    PLoS One. 2017;12:e0183444.
    PubMed     Abstract available


  295. HUO Z, Luo X, Zhan X, Chu Q, et al
    Genetic analysis of indel markers in three loci associated with Parkinson's disease.
    PLoS One. 2017;12:e0184269.
    PubMed     Abstract available


  296. SIMIELI L, Gobbi LTB, Orcioli-Silva D, Beretta VS, et al
    The variability of the steps preceding obstacle avoidance (approach phase) is dependent on the height of the obstacle in people with Parkinson's disease.
    PLoS One. 2017;12:e0184134.
    PubMed     Abstract available


  297. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Abstract available


  298. TUGAEVA KV, Tsvetkov PO, Sluchanko NN
    Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction.
    PLoS One. 2017;12:e0178933.
    PubMed     Abstract available


  299. RASSU M, Del Giudice MG, Sanna S, Taymans JM, et al
    Role of LRRK2 in the regulation of dopamine receptor trafficking.
    PLoS One. 2017;12:e0179082.
    PubMed     Abstract available


  300. MABROUK R, Strafella AP, Knezevic D, Ghadery C, et al
    Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    PLoS One. 2017;12:e0177785.
    PubMed     Abstract available


  301. SHRESTHA S, Kamel F, Umbach DM, Beane Freeman LE, et al
    Nonmotor symptoms and Parkinson disease in United States farmers and spouses.
    PLoS One. 2017;12:e0185510.
    PubMed     Abstract available


  302. HUANG SL, Hsieh CL, Wu RM, Lu WS, et al
    Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson's disease.
    PLoS One. 2017;12:e0184823.
    PubMed     Abstract available


  303. BEN EL HAJ R, Salmi A, Regragui W, Moussa A, et al
    Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.
    PLoS One. 2017;12:e0181335.
    PubMed     Abstract available


  304. YANG Y, Qin M, Bao P, Xu W, et al
    Secretory carrier membrane protein 5 is an autophagy inhibitor that promotes the secretion of alpha-synuclein via exosome.
    PLoS One. 2017;12:e0180892.
    PubMed     Abstract available


  305. NACHEVA E, Mokretar K, Soenmez A, Pittman AM, et al
    DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.
    PLoS One. 2017;12:e0180467.
    PubMed     Abstract available


  306. VAICIUKYNAS E, Verikas A, Gelzinis A, Bacauskiene M, et al
    Detecting Parkinson's disease from sustained phonation and speech signals.
    PLoS One. 2017;12:e0185613.
    PubMed     Abstract available


  307. DOUCET M, El-Turabi A, Zabel F, Hunn BHM, et al
    Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.
    PLoS One. 2017;12:e0181844.
    PubMed     Abstract available


  308. SCHLACHETZKI JCM, Barth J, Marxreiter F, Gossler J, et al
    Wearable sensors objectively measure gait parameters in Parkinson's disease.
    PLoS One. 2017;12:e0183989.
    PubMed     Abstract available


  309. GRAMSCH C, Reuter I, Kraff O, Quick HH, et al
    Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?
    PLoS One. 2017;12:e0185489.
    PubMed     Abstract available


  310. MIJALKOV M, Kakaei E, Pereira JB, Westman E, et al
    BRAPH: A graph theory software for the analysis of brain connectivity.
    PLoS One. 2017;12:e0178798.
    PubMed     Abstract available


  311. MORALES I, Sanchez A, Rodriguez-Sabate C, Rodriguez M, et al
    Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model.
    PLoS One. 2017;12:e0185989.
    PubMed     Abstract available


  312. ZONDLER L, Kostka M, Garidel P, Heinzelmann U, et al
    Proteasome impairment by alpha-synuclein.
    PLoS One. 2017;12:e0184040.
    PubMed     Abstract available


  313. MATSUI H, Sugie A
    An optimized method for counting dopaminergic neurons in zebrafish.
    PLoS One. 2017;12:e0184363.
    PubMed     Abstract available


  314. PICILLO M, Pivonello R, Santangelo G, Pivonello C, et al
    Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease.
    PLoS One. 2017;12:e0186508.
    PubMed     Abstract available


  315. PARK HJ, Ryu D, Parmar M, Giasson BI, et al
    The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
    PLoS One. 2017;12:e0184262.
    PubMed     Abstract available


  316. PERJU-DUMBRAVA L, Lau K, Phyland D, Papanikolaou V, et al
    Arytenoid cartilage movements are hypokinetic in Parkinson's disease: A quantitative dynamic computerised tomographic study.
    PLoS One. 2017;12:e0186611.
    PubMed     Abstract available


  317. MINATO T, Maeda T, Fujisawa Y, Tsuji H, et al
    Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
    PLoS One. 2017;12:e0187307.
    PubMed     Abstract available


  318. MORISHITA T, Hilliard JD, Okun MS, Neal D, et al
    Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
    PLoS One. 2017;12:e0183711.
    PubMed     Abstract available


  319. UCHINO K, Shiraishi M, Tanaka K, Akamatsu M, et al
    Impact of inability to turn in bed assessed by a wearable three-axis accelerometer on patients with Parkinson's disease.
    PLoS One. 2017;12:e0187616.
    PubMed     Abstract available


  320. ADAMS WR
    High-accuracy detection of early Parkinson's Disease using multiple characteristics of finger movement while typing.
    PLoS One. 2017;12:e0188226.
    PubMed     Abstract available


  321. BADEA L, Onu M, Wu T, Roceanu A, et al
    Exploring the reproducibility of functional connectivity alterations in Parkinson's disease.
    PLoS One. 2017;12:e0188196.
    PubMed     Abstract available


  322. NICOLETTI A, Mostile G, Stocchi F, Abbruzzese G, et al
    Factors influencing psychological well-being in patients with Parkinson's disease.
    PLoS One. 2017;12:e0189682.
    PubMed     Abstract available


  323. GODINO-LLORENTE JI, Shattuck-Hufnagel S, Choi JY, Moro-Velazquez L, et al
    Towards the identification of Idiopathic Parkinson's Disease from the speech. New articulatory kinetic biomarkers.
    PLoS One. 2017;12:e0189583.
    PubMed     Abstract available


  324. BAJAJ S, Krismer F, Palma JA, Wenning GK, et al
    Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0189897.
    PubMed     Abstract available


  325. PINHO R, Guedes LC, Soreq L, Lobo PP, et al
    Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.
    PLoS One. 2017;12:e0190552.
    PubMed     Abstract available


  326. ZHOU W, Barkow JC, Freed CR
    Running wheel exercise reduces alpha-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0190160.
    PubMed     Abstract available


  327. NACKAERTS E, Broeder S, Pereira MP, Swinnen SP, et al
    Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.
    PLoS One. 2017;12:e0190223.
    PubMed     Abstract available


  328. SILVA DE LIMA AL, Hahn T, Evers LJW, de Vries NM, et al
    Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease.
    PLoS One. 2017;12:e0189161.
    PubMed     Abstract available


  329. BARGIOTAS P, Eugster L, Oberholzer M, Debove I, et al
    Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    PLoS One. 2017;12:e0190027.
    PubMed     Abstract available


    January 2016
  330. YUAN J, Ren J, Wang Y, He X, et al
    Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.
    PLoS One. 2016;11:e0162696.
    PubMed     Abstract available


  331. MUN JK, Youn J, Cho JW, Oh ES, et al
    Weight Change Is a Characteristic Non-Motor Symptom in Drug-Naive Parkinson's Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational Study.
    PLoS One. 2016;11:e0162254.
    PubMed     Abstract available


  332. YANG W, Liu B, Huang B, Huang R, et al
    Altered Resting-State Functional Connectivity of the Striatum in Parkinson's Disease after Levodopa Administration.
    PLoS One. 2016;11:e0161935.
    PubMed     Abstract available


  333. MARIANI E, Frabetti F, Tarozzi A, Pelleri MC, et al
    Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.
    PLoS One. 2016;11:e0161567.
    PubMed     Abstract available


  334. ZHANG X, Ye YL, Zhu H, Sun SN, et al
    Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson's Disease.
    PLoS One. 2016;11:e0163372.
    PubMed     Abstract available


  335. MOREAU C, Devos D, Baille G, Delval A, et al
    Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?
    PLoS One. 2016;11:e0162904.
    PubMed     Abstract available


  336. ALMEIDA OP, McCaul K, Hankey GJ, Yeap BB, et al
    Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease.
    PLoS One. 2016;11:e0163781.
    PubMed     Abstract available


  337. DEWEY RB 3RD, O'Suilleabhain PE, Sanghera M, Patel N, et al
    Developing a Deep Brain Stimulation Neuromodulation Network for Parkinson Disease, Essential Tremor, and Dystonia: Report of a Quality Improvement Project.
    PLoS One. 2016;11:e0164154.
    PubMed     Abstract available


  338. DEAN DC 3RD, Sojkova J, Hurley S, Kecskemeti S, et al
    Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
    PLoS One. 2016;11:e0163774.
    PubMed     Abstract available


  339. WANG S, Zhang S, Xu C, Barron A, et al
    Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
    PLoS One. 2016;11:e0164465.
    PubMed     Abstract available


  340. SAN LUCIANO M, Wang C, Ortega RA, Yu Q, et al
    Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease.
    PLoS One. 2016;11:e0162799.
    PubMed     Abstract available


  341. GAO R, Zhang G, Chen X, Yang A, et al
    CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
    PLoS One. 2016;11:e0164762.
    PubMed     Abstract available


  342. YE R, Shen T, Jiang Y, Xu L, et al
    The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.
    PLoS One. 2016;11:e0164388.
    PubMed     Abstract available


  343. KIM D, Jeon H, Ryu S, Koo S, et al
    Proteomic Analysis of the Effect of Korean Red Ginseng in the Striatum of a Parkinson's Disease Mouse Model.
    PLoS One. 2016;11:e0164906.
    PubMed     Abstract available


  344. MAKOVAC E, Cercignani M, Serra L, Torso M, et al
    Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form.
    PLoS One. 2016;11:e0163980.
    PubMed     Abstract available


  345. LOVEREIDE L, Hagell P
    Measuring Life Satisfaction in Parkinson's Disease and Healthy Controls Using the Satisfaction With Life Scale.
    PLoS One. 2016;11:e0163931.
    PubMed     Abstract available


  346. PETSCHOW C, Scheef L, Paus S, Zimmermann N, et al
    Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study.
    PLoS One. 2016;11:e0164607.
    PubMed     Abstract available


  347. FUJITA H, Suzuki K, Numao A, Watanabe Y, et al
    Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    PLoS One. 2016;11:e0165869.
    PubMed     Abstract available


  348. KRONIMUS Y, Albus A, Balzer-Geldsetzer M, Straub S, et al
    Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
    PLoS One. 2016;11:e0164953.
    PubMed     Abstract available


  349. ZHANG Y, Wu IW, Tosun D, Foster E, et al
    Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    PLoS One. 2016;11:e0165540.
    PubMed     Abstract available


  350. JAVOR A, Ransmayr G, Struhal W, Riedl R, et al
    Parkinson Patients' Initial Trust in Avatars: Theory and Evidence.
    PLoS One. 2016;11:e0165998.
    PubMed     Abstract available


  351. KOMNIG D, Imgrund S, Reich A, Grunder S, et al
    ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease.
    PLoS One. 2016;11:e0165235.
    PubMed     Abstract available


  352. LU J, Cui J, Li X, Wang X, et al
    An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity.
    PLoS One. 2016;11:e0166415.
    PubMed     Abstract available


  353. HSU YC, Chang CW, Lee HL, Chuang CC, et al
    Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan.
    PLoS One. 2016;11:e0166552.
    PubMed     Abstract available


  354. KOPRICH JB, Johnston TH, Reyes G, Omana V, et al
    Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson's Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque.
    PLoS One. 2016;11:e0167235.
    PubMed     Abstract available


  355. LEE MJ, Son JS, Lee JH, Kim SJ, et al
    Impact of Prolonged Temporal Discrimination Threshold on Finger Movements of Parkinson's Disease.
    PLoS One. 2016;11:e0167034.
    PubMed     Abstract available


  356. JESUS S, Huertas I, Bernal-Bernal I, Bonilla-Toribio M, et al
    GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    PLoS One. 2016;11:e0167749.
    PubMed     Abstract available


  357. BRYAN L, Kaye W, Antao V, Mehta P, et al
    Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    PLoS One. 2016;11:e0153683.
    PubMed     Abstract available


  358. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Abstract available


  359. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: